Bausch Health Companies Financials - Benzinga

Bausch Health Companies Inc

BHCNYSE

Trade with Public

Trade with Public

$6.32

0.020.32%

At close: Aug 28, 5:00 PM EST

$6.32

N/A

After Hours: Aug 28, 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Bausch Health Companies Financials

Bausch Health Companies (BHC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est

Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.

Benzinga Newsdesk

PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B Estimate

Benzinga Newsdesk

PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate

Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.06 by 17.76 percent. This is a 38.46 percent increase over earnings of $0.91 per share

Benzinga Newsdesk

PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.625B-$10.875B to $10.670B-$10.920B vs $10.595B Est

Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.625 billion-$10.875 billion to $10.670 billion-$10.920 billion vs $10.595 billion estimate.

Benzinga Newsdesk

PRO
Bausch Health Companies Q1 Adj. EPS $0.78 Beats $0.69 Estimate, Sales $2.524B Beat $2.409B Estimate

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.69 by 13.04 percent. This is a 27.87 percent increase over earnings of $0.61 per share

Benzinga Newsdesk

Earnings Scheduled For April 29, 2026

Benzinga Insights